Alkermes (ALKS) Consolidated Net Income (2010 - 2026)
Alkermes' Consolidated Net Income came in at $16.34 million for Q3 2026, down 80.3% from $82.76 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Consolidated Net Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Alkermes reported Consolidated Net Income of -$324,000; for FY2025, it was $241.66 million, down 34.2% from FY2024.
- Going back by year, Consolidated Net Income was $367.07 million in FY2024 (+3.2%), $355.76 million in FY2023, -$158.27 million in FY2022 and -$48.17 million in FY2021.
- The five-year range for quarterly Consolidated Net Income is -$66.53 million (Q1 2026) to $237.07 million (Q2 2023).
- Year-over-year, Consolidated Net Income increased in 1 of the last seven quarters, with an average decline of 38.6%.
- The fastest year-over-year change in Consolidated Net Income over five years came in Q3 2024 (growth of 93.4%), and the weakest in Q2 2026 (a decline of 99.4%).
- Business Quant data shows ALKS's Consolidated Net Income at $524,000 (Q2 2026), -$66.53 million (Q1 2026) and $49.34 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 16.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.34 Mn |
| Jun 30, 2026 | 524,000.00 |
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.34 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 146.50 Mn |
| Sep 30, 2024 | 92.38 Mn |
| Jun 30, 2024 | 91.36 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 112.78 Mn |
| Sep 30, 2023 | 47.76 Mn |
| Jun 30, 2023 | 237.07 Mn |
| Mar 31, 2023 | -41.85 Mn |
| Dec 31, 2022 | 96.86 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 125.44 Mn |
API Access
Alkermes Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();